Skip to content
Sonic
AI
Sonic
AI
Home
Discover
Ask Sonic
Projects
Use with Claude or ChatGPT
Show me around
Request source or feature
Luma Group CEO Josh Fink at Semafor World Economy, Sonic AI
Home
/
Semafor World Economy Summit 2026
/
Luma Group CEO Josh Fink at Semafor World Economy
Semafor World Economy Summit 2026
Notify me
•
May 1, 2026
•
14:52
Conference
Interview
Luma Group CEO Josh Fink at Semafor World Economy
From
Semafor World Economy Summit 2026
· 2026
Josh Fink
(CEO, Luma Group, guest)
Get the full transcript next time Semafor World Economy Summit 2026 releases an episode
Summary, key quotes, top claims, and the searchable transcript — emailed automatically. No card needed.
Sign up
Executive Summary
Specialized AI, not general LLMs, is transforming drug discovery by analyzing complex biological data, enabling breakthroughs like a potential cure for macular degeneration.
The biotech M&A market is surging, driven by Big Pharma's need to acquire innovation to offset a looming '$300 billion patent cliff' and reinvest profits from drugs like GLP-1s.
faces a significant national security threat from China's rapidly advancing biotech sector, which has shifted from imitation to genuine de novo innovation.
Maintaining U.S.
leadership in biotech hinges on protecting intellectual property for AI-driven discoveries, fostering talent, and ensuring deep capital markets for investment.
Continue your research
Keep pulling the thread on Josh Fink.
The Application of AI in Biotechnology
Biotech Investment and M&A Dynamics
12
quotes
Transcript
Key Arguments
Analysis
Quotes & Entities
12
Related
Loading transcript...
Processed May 10, 2026
Daily intelligence brief →
yt-dlp + mlx-whisper + Gemini